8MW2311
/ Mabwell (Shanghai) Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 20, 2024
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=216 | Suspended | Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Recruiting ➔ Suspended
Metastases • Trial suspension • Oncology • Solid Tumor
August 31, 2022
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=216 | Recruiting | Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
June 13, 2022
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=216 | Not yet recruiting | Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
New P1/2 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1